Endometrial cancer drug gets breakthrough therapy designation

HUTCHMED has announced that the NMPA has granted Breakthrough Therapy Designation for its advanced endometrial cancer treatment.

Related Keywords

Japan ,China ,Eli Lilly ,Innovent Biologics Inc ,European Medicines Agency ,Hutchmed China ,Drug Administration ,Japan Pharmaceuticals ,National Reimbursement Drug List ,Takeda Pharmaceutical Company ,Devices Agency ,Drug Evaluation ,National Medical Products Administration ,Breakthrough Therapy Designation ,Prescription Drug User Fee Act ,Medical Devices Agency ,Takeda Pharmaceutical Company Limited ,Innovent Biologics ,